[DOI] [PMC free article] [PubMed] [Google Scholar] 29
Chronobiology and Pharmacologic Modulation of the Renin-Angiotensin-Aldosterone System in Dogs: What Have We Learned
You can read the abstract of this article at LY3437943, a novel triple GIP, GLP-1, and glucagon receptor agonist in people with type 2 diabetes: a phase 1b, multicentre, double-blind, placebo-controlled, randomised, multiple-ascending dose trial PubMed (nih.gov)
Short-acting GLP-1 RAs (e.g., exenatide, lixisenatide) were found to have a reduced impact on overnight and fasting blood glucose levels, while long-acting GLP-1 RAs (liraglutide, exenatide once weekly, dulaglutide, and semaglutide) were found to have an increased effect and better coverage on overnight and fasting blood glucose and HbA1c levels [18]
Prescription supplement protocols were extended into provincial hospital systems, where clinical dietitians began recommending digestion-friendly, low-glycemic formulas
Some patients also reported moderate-to-mild urinary tract infection or skin discomfort